Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 78.35
+0.11 (0.14%)
Apr 3, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 31.87 billion as of April 3, 2025. Its market cap has increased by 30.06% in one year.
Market Cap
31.87B
Enterprise Value
31.22B
Revenue
2.82B
Ranking
n/a
PE Ratio
38.60
Stock Price
78.35
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 31.87B, an increase of 121.95%. That is a compound annual growth rate of 16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 31.87B | 6.79% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 323.33B |
| Shenzhen Mindray Bio-Medical Electronics | 277.99B |
| WuXi AppTec | 189.97B |
| Aier Eye Hospital Group | 123.28B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.56B |
| Shanghai United Imaging Healthcare | 101.95B |
| Yunnan Baiyao Group Co.,Ltd | 101.36B |
| Sichuan Biokin Pharmaceutical | 99.04B |